{
    "Title": "Revisiting the Loa loa microfilaremia thresholds above which serious adverse events may occur with ivermectin treatment",
    "URL": "https://doi.org/10.1371/journal.pntd.0012957",
    "Published": "March 28, 2025",
    "Subject_Areas": [
        "Loa loa",
        "Medical risk factors",
        "Loiasis",
        "Age groups",
        "Treatment guidelines",
        "Adverse events",
        "Cameroon",
        "Drug therapy"
    ],
    "Authors": {
        "Charlotte Boullé": [
            "UMI 233, Institut de Recherche pour le Développement, INSERM Unité, Université de Montpellier, Montpellier, France",
            "Department of Infectious and Tropical Diseases, Montpellier University Hospital, Montpellier, France"
        ],
        "Sébastien D. Pion": [
            "UMI 233, Institut de Recherche pour le Développement, INSERM Unité, Université de Montpellier, Montpellier, France"
        ],
        "Jacques Gardon": [
            "Hydrosciences Montpellier, Université de Montpellier, Institut de Recherche pour le Développement, Centre National de la Recherche Scientifique, Montpellier, France"
        ],
        "Nathalie Gardon-Wendel": [
            "Centre Pasteur, Yaoundé, Cameroon"
        ],
        "Joël Fokom Domgue": [
            "Department of Epidemiology, The University of Texas M.D. Anderson Cancer Center, Houston, Texas, United States of America"
        ],
        "Joseph Kamgno": [
            "Higher Institute for Scientific and Medical Research, Yaoundé, Cameroon",
            "Faculty of Medicine and Biomedical Sciences, University of Yaoundé I, Yaoundé, Cameroon"
        ],
        "Cédric B. Chesnais": [
            "UMI 233, Institut de Recherche pour le Développement, INSERM Unité, Université de Montpellier, Montpellier, France"
        ],
        "Michel Boussinesq": [
            "UMI 233, Institut de Recherche pour le Développement, INSERM Unité, Université de Montpellier, Montpellier, France"
        ]
    }
}